Mathias Vilaine

发表

Mpl Traffics to the Cell Surface Through Conventional and Unconventional Routes

Mark Ellisman, S. Hermouet, M. Steinkamp, 2014, Traffic.

The Hepatocyte Growth Factor (HGF)/Met Axis: A Neglected Target in the Treatment of Chronic Myeloproliferative Neoplasms?

M. Boissinot, S. Hermouet, M. Vilaine, 2014, Cancers.

Anti-inflammatory cytokines hepatocyte growth factor and interleukin-11 are over-expressed in Polycythemia vera and contribute to the growth of clonal erythroblasts independently of JAK2V617F

M. Boissinot, S. Hermouet, C. Cleyrat, 2011, Oncogene.

Identification of a new VHL exon and complex splicing alterations in familial erythrocytosis or von Hippel-Lindau disease.

R. Redon, K. Schwarz, S. Knight, 2018, Blood.

New lessons from an old gene: complex splicing and a novel cryptic exon in VHL gene cause erythrocytosis and VHL disease Complex genetics in VHL disease and erythrocytosis

R. Redon, K. Schwarz, S. Knight, 2018 .

Homologous recombination of wild-type JAK2, a novel early step in the development of myeloproliferative neoplasm.

R. Kralovics, S. Hermouet, Jian-Min Chen, 2011, Blood.

The JAK2 46/1 haplotype: a marker of inappropriate myelomonocytic response to cytokine stimulation, leading to increased risk of inflammation, myeloid neoplasm, and impaired defense against infection?

S. Hermouet, M. Vilaine, Mathias Vilaine, 2011, Haematologica.

Identification of a new VHL exon and complex splicing alterations in familial erythrocytosis or von Hippel-Lindau disease.

R. Redon, K. Schwarz, S. Knight, 2018, Blood.

Germline MPLW515R Mutation in a Family with Isolated Thrombocytosis

R. Kralovics, F. Girodon, S. Hermouet, 2012 .

The JAK2 46/1 haplotype: a marker of inappropriate myelomonocytic response to cytokine stimulation, leading to increased risk of inflammation, myeloid neoplasm, and impaired defense against infection?

F. Danjou, F. Anni, R. Galanello, 2011, Haematologica.